Primary Care Clinics in Scarborough, ME Accepting Medicare
10 Primary Care Clinics found. Showing 1 - 10
 Metabolic Leader Llc Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 51 Us Route 1 Ste H, Scarborough, ME 04074 Phone: 207-396-6433 Fax: 207-396-6436 |
Maine Medical Partners Family Medicine Family Medicine Medicare: Medicare Enrolled Practice Location: 300 Professional Dr, Scarborough, ME 04074 Phone: 207-883-3491 |
Maine Medical Partners Scarborough Family Medicine Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 Professional Dr, Scarborough, ME 04074 Phone: 207-883-3491 Fax: 207-883-5587 |
Whole Medicine Llc Family Medicine Medicare: Medicare Enrolled Practice Location: 2o Mussey Road, Suite 2, Scarborough, ME 04074 Phone: 207-885-1333 |
Scarborough Integrative Health, P.a. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 51 Us Route 1 Ste A, Scarborough, ME 04074 Phone: 207-396-1440 Fax: 207-289-3104 |
Scarborough Health Care Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 69 Us Route 1, 6 Science Park Road, Scarborough, ME 04074 Phone: 207-883-8100 Fax: 207-883-8756 |
Kenneth Ault Md Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 81 Research Dr, Scarborough, ME 04074 Phone: 207-885-8130 Fax: 207-885-8110 |
Andrew Candelore, Do Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 617 Us Route 1, Scarborough, ME 04074 Phone: 207-883-5149 Fax: 207-883-7885 |
A J Candelore Do Pllc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 617 Us Route 1, Scarborough, ME 04074 Phone: 207-883-5149 Fax: 207-883-7885 |
Results Speech And Language Therapy, Pllc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 20 Mussey Rd Ste 203, Scarborough, ME 04074 Phone: 207-400-5368 |
News Archive
Genomic Health presents 11 studies demonstrating value of Oncotype DX breast cancer test
Genomic Health today announced the presentation of 11 studies with the Oncotype DX breast cancer test at the 14th St. Gallen Breast Cancer Conference in Vienna, Austria. Studies presented include results from a real-life observational study in Ireland demonstrating significant reductions in chemotherapy and resulting cost savings when the test is used in early stage breast cancer.
Somaxon's Silenor now commercially available in U.S.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that Silenor® (doxepin) now is commercially available by prescription in the United States. Somaxon has implemented a wholesale and retail stocking program to disseminate Silenor 3 mg and 6 mg dosepacks to pharmacies across the United States. Silenor is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance.
HT-4X centrifugal evaporator from Genevac provides optimised sample preparation capabilities for drug discovery
The HT-4X centrifugal evaporator from Genevac provides optimised sample preparation capabilities for scientists working in the drug discovery environment.
Economy continues to impact finances of health companies
Despite a sluggish year, health care investors can look forward to growing emerging markets and a possible change in the U.S. political climate, Forbes reports. "Health care has not had a banner year in 2010 as the sector's stocks have underperformed the market on account of reform in the United States and financial problems in Europe. But there's hope for investors in shares of companies that stand on their own fundamentals, particularly those that have been successful in growing sales to emerging markets.
BioDiscovery, Affymetrix enter co-marketing agreement for OncoScan FFPE Express Service
Affymetrix, Inc. today announced a co-marketing agreement naming BioDiscovery, Inc. its preferred software provider for Affymetrix OncoScan FFPE Express Service data analysis.
› Verified 2 days ago